Titlebook: Cell Therapy for Perinatal Brain Injury; Haruo Shintaku,Akira Oka,Makoto Nabetani Book 2018 Springer Nature Singapore Pte Ltd. 2018 Stem c

憑票入場

書目名稱Cell Therapy for Perinatal Brain Injury影響因子(影響力)




書目名稱Cell Therapy for Perinatal Brain Injury影響因子(影響力)學(xué)科排名




書目名稱Cell Therapy for Perinatal Brain Injury網(wǎng)絡(luò)公開度




書目名稱Cell Therapy for Perinatal Brain Injury網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Cell Therapy for Perinatal Brain Injury被引頻次




書目名稱Cell Therapy for Perinatal Brain Injury被引頻次學(xué)科排名




書目名稱Cell Therapy for Perinatal Brain Injury年度引用




書目名稱Cell Therapy for Perinatal Brain Injury年度引用學(xué)科排名




書目名稱Cell Therapy for Perinatal Brain Injury讀者反饋




書目名稱Cell Therapy for Perinatal Brain Injury讀者反饋學(xué)科排名

失望昨天

上釉彩

Pathophysiology and Pathology of Neonatal Hypoxic-Ischemic Encephalopathy,unique. The mode of cell death includes necrosis and apoptosis. Necrosis occurs in conditions of primary energy failure following the initial injury. On the other hand, apoptosis occurs days after the initial injury. The damaged area in the brain depends on the mode of injury. Severe and prolonged i

尾隨

鑲嵌細(xì)工

Hematopoietic Stem Cells for Perinatal Brain Injury,r cell-based therapies for perinatal brain injury. Nearly 20 studies in models of perinatal brain injury, most of which are rodent models of neonatal hypoxia-ischemia, have histologically and functionally demonstrated beneficial effects of systemic administration of HSCs and the related cell fractio

愛了嗎

Umbilical Cord-Derived Mesenchymal Stromal Cells for Perinatal Brain Injury,ons including (1) no adverse events during collection, (2) ease of collection even after cord blood (CB) collection or failure to collect CB, (3) minimal ethical controversy, (4) multipotency to differentiate into various cell types, and (5) low immunogenicity with significant immunosuppressive abil

愛了嗎

Other Tissues-Derived Mesenchymal Stem Cells for Perinatal Brain Injury, in preclinical models of HIE. However, despite their neural commitment, ethical concerns hinder the use of postmortem human brains as a source of NSPCs in future clinical applications. Furthermore, intracerebral administration is an invasive procedure..Stem cells originating from nonneural tissues

BARK

CD34+ Cell in Cord Blood and Neonates,opoietic and non-hematopoietic stem/progenitor cells. This chapter focuses on recent progresses in stem cell biology on cord blood cells. During embryonic development, expression of CD34 is tightly regulated in a spatial and temporal manner. Subpopulations of CD34. cells in cord blood have been char

agonist

The History of Hypothermia Therapy for Perinatal Ischemic Brain Injury,y starts and proceed to Consensus 2010 in which hypothermia therapy should be recommended for newborns with moderate to severe hypoxic-ischemic encephalopathy (HIE). Next I talk about how hypothermia therapy spreads and could be standardized on the guideline and nationwide online registry system in

侵略主義

Clinical Procedure of Cell Therapy: Cord Blood Collection,ed in the United States (Michael et al. J Pediatr 164:973–979, 2014). We have thus decided to initiate a similar clinical trial in Japan and set obstetric criteria for the indication of cell therapy. Written consent for UCB collection was obtained following successful collection, as the cases includ